Latest BioAlps news
News
ExcellGene celebrates 25 years of biotechnology innovation
Based in Monthey (VS) since 2003, ExcellGene last week celebrated 25 years of biotechnology innovation also marking the leadership transition…
News
HUG to Lead a Major Trial Testing Cell Therapy for Advanced Heart Failure
Geneva University Hospitals (HUG) has received over CHF 1 million from the Swiss National Science Foundation to take part in…
News
Twice as many Swiss now ask AI about their symptoms
The 2026 CSS Health Study shows chatbots are fast becoming part of how people in Switzerland manage their health, from…
News
Ibex Therapeutics Secures CHF 640,000 in Grant Funding from Innosuisse
The Valais-based start-up is accelerating the development of its lead candidate in partnership with the Geneva University Hospitals (HUG) and…
News
Apolarion receives CHF 150,000 from Venture Kick
The EPFL spin-off Apolarion has obtained CHF 150,000 from Venture Kick to advance a chemical-free seed treatment technology powered by…
News
Lonza Acquires Acquires Five CDMO Manufacturing Sites in the US
Lonza, the largest Swiss Health Valley🇨🇭 company, signs an agreement with Merck KGaA to acquire five CDMO manufacturing sites and…
News
Nagi Bioscience and InVirtuoLabs join forces to bring whole-organism biology into AI drug discovery
Nagi Bioscience, an EPFL spin-off based at EPFL Innovation Park, has announced a new partnership with InVirtuoLabs, based in Ticino,…
News
Distalmotion Secures Up to $70 Million Term Loan to Accelerate US Expansion
Distalmotion, a global MedTech company based à Biopôle-Lausanne and focused on expanding access to robotic surgery in outpatient settings, announced…
News
Neurosterix announces the success of a Phase I trial for NTX-253
The drug candidate, intended for the treatment of schizophrenia, is now set to enter Phase II. Addex holds a 20…
News
Biodelphis Therapeutics, PolaSight and Swiss Soil each receive a Tech Seed loan
The Foundation for Innovation and Technology (FIT) is supporting three life sciences start-ups through Tech Seed loans. Biodelphis Therapeutics is…
News
BioAlps Networking Day – Meet the Exhibitors
About fifteen exhibitors will be waiting for you at the BioAlps Networking Day on 19 November 2026 at Beaulieu Lausanne….
News
Release Therapeutics Secures Non-Dilutive Innosuisse Funding
Release Therapeutics, a privately held Swiss BioMedTech company based at Campus Biotech in Geneva, announced that it has been awarded…